Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine vs Sufentanil for Postoperative Analgesia and Delirium in Elderly Hip Fracture Surgery
ChiCTR2600115914Phase 4Not yet recruiting
- Sponsor
- Henan Provincial People's Hospita,medical
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of oliceridine in postoperative pain and postoperative delirium (POD) (2 arms), sponsored by Henan Provincial People's Hospita,medical. Primary endpoint: Incidence of postoperative delirium. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
postoperative painpostoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR2600115914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600115914.